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 ABSTRACT
Medication-related osteonecrosis of the jaw: 
a 4-year experience 
R. Marino, P.F. Menduni, M. Berrone, V. R. Carbone, S. Gan-
dolfo, M. Pentenero
Department of Oncology, Oral Medicine and Oral Oncology 
Unit, University of Turin, Orbassano (TO), Italy 
Aim. Bisphosphonates, antiresorptive (mainly Deno-
sumab) and antiangiogenic therapies are widely used in 
the management of metastatic disease involving the bone 
and in the treatment of osteoporosis. Patients are referred 
to our clinic aiming to: 1) evaluate the oral conditions of 
the oncologic and osteoporotic patients before the be-
ginning of the therapy with bisphosphonate in order to 
reduce as less as possible the oral risk factors, 2) follow 
up patients during all the period of treatment in order to 
intercept as soon as possible the onset of the disease and 
3) plan the treatment in case of bone necrosis. 
Methods. Data on patients observed in a 4 years pe-
riod have been collected with particular attention for in-
dications to treatment, medication type, incidence, treat-
ment and prognosis of medication-related osteonecrosis 
of the jaw (MRONJ). 
Results. From May 2011 until December 2014, 199 
patients (84 males, 115 females) taking bisphosphonates 
or antiresorptive or antiangiogenic drugs were referred 
to our Department. Patients with oncologic diseases 
represents the 90% of subjects: 20% were affected from 
breast cancer, 32,6% prostate cancer, 15,5% lung cancer, 
28,2% other malignant tumors with bone metastases. 
Osteoporotic patients represented only 10% of the sam-
ple and treated with oral bisphosphonates (alendro-
nate). MRONJ occurred in 28/199 patients (14%), after a 
mean latency time of 36 months after the first assump-
tion of medication. 68% of patients with MRONJ (19/28) 
were oncologic patients. 42% were affect of breast can-
cer, 15% prostate cancer, 15% multiple myeloma and 
28% other tumors. The most relevant complication was 
pain, observed in 80% of cases. 60% of the MRONJ was 
localized in the mandible, 35% in the maxilla, and 5% in 
both mandible and maxilla. 57% of the MRONJ occurred 
after extractive procedures, 18% in patients with remov-
able prosthesis, 20% were considered spontaneous and 
only 5% occurred on a site of periodontal disease. Sur-
gical treatment was performed in case of exposed and 
necrotic bone or fistulas that probes to bone associated 
with infection as evidenced by pain and erythema in 
the region of exposed bone with or without purulent 
drainage (stage 2). On the base of such indications, 16 
patients were treated, with 2 patients presenting relapse 
in less than 6 months, corresponding to a success rate of 
88%. Patients were mainly treated under local anaesthe-
sia, only with performing debridement of necrotic bone. 
In six cases (stage 3) the extension of bone necrosis re-
quired a segmental ostectomy under general anaesthe-
sia. These surgical approaches had similar success rate. 
Conclusion. Since the discovery of bisphosphonates-
related osteonecrosis of the jaw, there has been increas-
ing evidence in recent years of osteonecrosis induced by 
drugs other than bisphosphonates, mainly agents with 
antiangiogenic and antiosteoclastic activity. Patients as-
suming antiresorptive medications for osteoporosis are 
less often referred for prevention of MRONJ and usu-
ally come to specialized clinics when MRONJ is already 
underway. 
drug, could be associated with an incresead risk. The 
discontinuation of both drugs was found to be associ-
ated to the spontaneous healing. 
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Aim. Calcifying epithelial odontogenic tumor (CEOT) 
is a rare, benign, locally aggressive odontogenic epi-
thelial tumor that affects the jaws. It is also referred as 
Pindborg tumor. 
Topographically two entities have been distinguished: 
intraosseous (central) and extraosseous (peripheral). 
Numerous surgical treatment modalities have been sug-
gested, and the treatment plan is dependent on multiple 
factors such as size and location of neoplasm, general 
condition of patient and operator skill. Small lesions 
with not bone involvement and well-defined borders 
could be treated by conservative surgical approach. The 
aim of this case report was to propose a new treatment 
modality of peripheral CEOT using Er, Cr: YSGG laser. 
Methods. A 55-year-old male was referred to our 
oral medicine surgery for a single, slow growing, pain-
less, fibrous, gingival swelling. Past and medical history 
did not reveal any relevant information. He was taking 
no medication and had no history of known drug al-
lergy. The intra-oral examination revealed a sessile mass 
of approximately 1,2 x 0,7 x 0,3 cm in size involving 
the left lingual mandibular alveolar process. The over-
lying mucosa showed an ulcer due to chronic trauma 
by chewing. On palpation, growth was no tender, no 
fluctuant, hard and fibrous in consistency. CT-scans 
did not indicate any bone involvement. Treatment plan 
comprising of excisional biopsy of the lesion using an 
Er, Cr: YSGG laser was planned. An incision was made 
including the overall mass, the lesion was lifted along 
with the underlying perosteum from the bone surface 
and removed. Haemostasis was achieved by laser and 
healing was obtained for second intention. The speci-
men was sent for histological examination. 
Results. Histopathological assessment showed sheets 
of polyhedral epithelial cells with well-defined borders, 
arranged in a pseudoglandular pattern. The cells were 
separated by thin bands of connective tissue in areas 
showing deposits of amorphous eosinophilic material. 
Small foci of calcifications were also noted. Diagnosis of 
CEOT was formulated. The postoperative course of the 
patient was uneventful, and there was no evidence of 
disease at the 2-year follow-up. 
Conclusion. A new conservative surgical treatment 
with Er, Cr: YSGG laser was proposed for the treatment 
of a peripheral CEOT. This approach was possible since 
the lesion was small without characteristics of malig-
nancy. It appeared to be efficient being minimally in-
vasive and offering many clinical advantages (minimal 
intra-operative bleeding, haemostasis, reduced times of 
healing). 
